<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2025.1657090</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Knowledge and attitudes of medical students regarding human papilloma virus infection and vaccine: cross-sectional study from Jordan</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Taha</surname>
<given-names>Hana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1291975/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alhawamdeh</surname>
<given-names>Taher</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alkhaldi</surname>
<given-names>Sireen M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ali Albsoul</surname>
<given-names>Rania</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3059904/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al-Ani</surname>
<given-names>Abdallah</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1740726/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Awamleh</surname>
<given-names>Suhib</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2991682/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al-Maayeh</surname>
<given-names>Amin Y.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qaqish</surname>
<given-names>Arwa</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mahmoud</surname>
<given-names>Ameen</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3024385/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abu-Surrah</surname>
<given-names>Diana</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2981520/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berggren</surname>
<given-names>Vanja</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Family and Community Medicine, School of Medicine, The University of Jordan</institution>, <addr-line>Amman</addr-line>,&#xa0;<country>Jordan</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Neurobiology, Care Science and Society, Karolinska Institutet</institution>, <addr-line>Stockholm</addr-line>,&#xa0;<country>Sweden</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Primary Healthcare Department, King Khalid Hospital</institution>, <addr-line>Kharj</addr-line>,&#xa0;<country>Saudi Arabia</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Office of Scientific Affairs and Research, King Hussein Cancer Center</institution>, <addr-line>Amman</addr-line>,&#xa0;<country>Jordan</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Faculty of Medicine, The Hashemite University</institution>, <addr-line>Zarqa</addr-line>,&#xa0;<country>Jordan</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Biology and Biotechnology, Faculty of Science, The Hashemite University</institution>, <addr-line>Zarqa</addr-line>,&#xa0;<country>Jordan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1506003/overview">Dhaneshwar Kumar</ext-link>, National Institute of Diabetes and Digestive and Kidney Diseases (NIH), United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/509350/overview">Javeed Ahmad</ext-link>, National Institute of Allergy and Infectious Diseases (NIH), United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3127096/overview">Mohammed Abdelaziz</ext-link>, Mansoura University, Egypt</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Hana Taha, <email xlink:href="mailto:hanagh@yahoo.com">hanagh@yahoo.com</email>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>&#x2020;ORCID: Hana Taha, <uri xlink:href="https://orcid.org/0000-0001-8710-8249">orcid.org/0000-0001-8710-8249</uri>; Sireen M. Al Khaldi, <uri xlink:href="https://orcid.org/0000-0002-7584-4502">orcid.org/0000-0002-7584-4502</uri>; Rania Ali Albsoul, <uri xlink:href="https://orcid.org/0000-0002-2613-5574">orcid.org/0000-0002-2613-5574</uri>; Abdalla Al-Ani, <uri xlink:href="https://orcid.org/0000-0002-3517-3601">orcid.org/0000-0002-3517-3601</uri>; Suhib Awamleh, <uri xlink:href="https://orcid.org/0009-0002-6031-6480">orcid.org/0009-0002-6031-6480</uri>; Arwa Qaqish, <uri xlink:href="https://orcid.org/0000-0002-1228-961X">orcid.org/0000-0002-1228-961X</uri>; Vanja Berggren, <uri xlink:href="https://orcid.org/0000-0001-7193-1150">orcid.org/0000-0001-7193-1150</uri>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1657090</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>08</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Taha, Alhawamdeh, Alkhaldi, Ali Albsoul, Al-Ani, Awamleh, Al-Maayeh, Qaqish, Mahmoud, Abu-Surrah and Berggren.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Taha, Alhawamdeh, Alkhaldi, Ali Albsoul, Al-Ani, Awamleh, Al-Maayeh, Qaqish, Mahmoud, Abu-Surrah and Berggren</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>As of the present moment, Jordan is yet to incorporate cervical cancer screening in its cancer control program nor advocates for vaccines. This paper aims to examines the perceptions and attitudes of medical students towards HPV and its vaccine.</p>
</sec>
<sec>
<title>Methods</title>
<p>We conducted a cross-examination of HPV knowledge and vaccine uptake among medical students across the period between January and March 2024. Participants completed a questionnaire developed and validated by the existing literature. The questionnaire was composed of 4 domains pertaining to sociodemographic, knowledge of HPV, knowledge of HPV vaccine, and attitudes. Medical students were conveniently sampled from Jordan&#x2019;s six public medical schools. Predictors to self-vaccinate, recommending vaccination to friends/family, and recommending vaccination to patients were examined using a binary logistic regression model. All analyses were conducted on R version (4.3.3).</p>
</sec>
<sec>
<title>Results</title>
<p>A total of 473 medical students were included in the final analysis. On a scale of 12 and 8, mean HPV and vaccine knowledge scores were 5.4 &#xb1; 3.1 and 2.9 &#xb1; 1.9, respectively. Knowledge of HPV and its vaccine were significantly higher among females, students in their clinical years, and those with self-perceived understanding of HPV (all p &lt;0.05). Intention to self-vaccinate against HPV was predicted by higher HPV and vaccine knowledge scores. Male participants were significantly less likely to self-vaccinate compared to females (OR: 0.61; 95%CI: 0.40 &#x2013; 0.91). Similarly, higher HPV and vaccine knowledge scores were associated a higher likelihood to recommend the vaccine to family or patients. On the other hand, male participants were significantly less likely to recommend the vaccine to patients compared to their female counterparts (OR: 0.62; 95%CI: 0.40 &#x2013; 0.95).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The study implies that the overall awareness and attitudes regarding HPV and its vaccine is alarmingly poor among medical students. Moreover, there exists a gender difference in the knowledge and attitudes favoring females. Concerned policy makers and institutions should strive to improve vaccine awareness and uptake through informational, behavioral, and environmental interventions. Moreover, medical students should be well equipped to tackle HPV vaccine hesitancy through curricular reforms, targeted training, and increased exposure to public vaccine promotional efforts.</p>
</sec>
</abstract>
<kwd-group>
<kwd>human papilloma virus</kwd>
<kwd>Jordan</kwd>
<kwd>medical education</kwd>
<kwd>knowledge</kwd>
<kwd>vaccine</kwd>
</kwd-group>
<contract-sponsor id="cn001">Karolinska Institutet<named-content content-type="fundref-id">10.13039/501100004047</named-content>
</contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="52"/>
<page-count count="11"/>
<word-count count="5126"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Virus and Host</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Background</title>
<p>Human papillomaviruses (HPV) are double-stranded DNA non-enveloped viruses that are associated with carcinogenesis (<xref ref-type="bibr" rid="B1">Abdelaziz et&#xa0;al., 2025</xref>). HPV infects squamous epithelial cells in the skin and mucosa and usually causes benign warts. However, persistent infection with high-risk oncogenic HPV strains causes cervical, anal, vulvar, vaginal, penile and oropharyngeal cancers.</p>
<p>(<xref ref-type="bibr" rid="B1">Abdelaziz et&#xa0;al., 2025</xref>). HPV have almost 200 genotypes and are categorized as high- or low-risk per their capacity to cause cancer. HPV is commonly transmitted through sexual or skin-to-skin contact among other mediums (<xref ref-type="bibr" rid="B6">Albayat et&#xa0;al., 2024</xref>). While most HPV infections resolve spontaneously, others may persist causing skin lesions, genital warts, or cancer (<xref ref-type="bibr" rid="B19">de Sanjos&#xe9; et&#xa0;al., 2018</xref>). With more than 300 million affected women worldwide, HPV infection is considered a global public health concern (<xref ref-type="bibr" rid="B29">Kombe Kombe et&#xa0;al., 2021</xref>). In fact, 12% of women with normal cervical cytology are carrier of HPV.</p>
<p>According to the World Health Organization (WHO) global statistics, HPV is responsible for an estimated 620,000 and 70,000 cancer cases in women and men, respectively (<xref ref-type="bibr" rid="B51">World Health Organization, 2024</xref>). Of these cancers, cervical cancer is associated with the most significant morbidity and mortality as it is the fourth cause of death across all female cancers (<xref ref-type="bibr" rid="B47">Sung et&#xa0;al., 2021</xref>). Fortunately, the risk of HPV infections can be mitigated by vaccines. As of writing this study, three vaccine types have been approved to prevent HPV genotypes implicated in cervical cancer (<xref ref-type="bibr" rid="B50">Wang et&#xa0;al., 2020</xref>). Current evidence points to the high safety and efficacy of these commercially available HPV vaccines despite the need for long-term studies (<xref ref-type="bibr" rid="B38">Porras et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B9">Alsanafi et&#xa0;al., 2023</xref>).</p>
<p>In the Middle East and North Africa (MENA) region, there are significant barriers to the uptake of the HPV vaccine. These include financial restraints, poor infrastructure, competition with other vaccines, and general lack of awareness (<xref ref-type="bibr" rid="B1">Abdelaziz et&#xa0;al., 2025</xref>). However, these barriers are context sensitive to the cultural and religious norms characterizing the MENA nations. Such factors could reduce the effectiveness of vaccination campaigns or increase resistant to its uptake among both the general public and medical students. Nonetheless, the literature shows that gaps in HPV knowledge exists also for healthcare professionals (<xref ref-type="bibr" rid="B43">Sallam et&#xa0;al., 2022</xref>).</p>
<p>While exact numbers on HPV infections and HPV-associated cancers in Jordan are currently unavailable, one study of 650 cases referred from gynecology clinics found HPV in 25.7% of native Jordanians&#x2019; samples (<xref ref-type="bibr" rid="B13">Annab et&#xa0;al., 2025</xref>). Estimates suggest that 115 women are diagnosed with cervical cancer, and 71 women die from the disease every year in Jordan (<xref ref-type="bibr" rid="B26">HPV Information Centre</xref>). Considering that 90% of cervical cancer cases are preventable through HPV vaccination (<xref ref-type="bibr" rid="B15">CDC, 2025</xref>), this emphasizes the vital role of vaccination as a preventive measure.</p>
<p>Currently, Jordan lacks a national screening program for cervical cancer nor includes HPV as part of its national immunization policy. Moreover, this is complicated by the lack of reliable data and updates on the prevalence of HPV across the kingdom (<xref ref-type="bibr" rid="B30">Mahafzah et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B39">Qaqish et&#xa0;al., 2023</xref>). Therefore, this paper aims to examine the understanding and awareness and the attitudes towards HPV infection among Jordanian medical students and the factors influencing vaccine uptake.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2_1">
<title>Study settings</title>
<p>Medical education in Jordan has evolved in the last 50 years with the establishment of several medical schools and teaching hospitals around the country. Currently in Jordan, there are approximately 10,000 medical students, with 1500 graduates per year (<xref ref-type="bibr" rid="B44">Sarhan et&#xa0;al., 2025</xref>). This study recruited students from all six public medical schools in Jordan (University of Jordan, Hashemite University, Balqa Applied University, Jordan University of Science and Technology, Mut&#x2019;ah University, and Yarmouk University). Participants were from both basic and clinical years. The choice of medical students was purposive, given their role as future practitioners, highlighting their importance in raising awareness, promoting vaccine advocacy, and public health interventions related to HPV in Jordan.</p>
</sec>
<sec id="s2_2">
<title>Study design</title>
<p>A cross-sectional descriptive study was conducted between January and March 2024. This design was selected to provide a snapshot of the current awareness and attitudes towards HPV because it is practical and cost-effectiveness for establishing baseline data on HPV knowledge and vaccine uptake.</p>
</sec>
<sec id="s2_3">
<title>Measurement tool</title>
<p>The questionnaire for this study (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary 1</bold>
</xref>) was developed based on existing literature (<xref ref-type="bibr" rid="B27">Khalil et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B33">Nesser and Ayodele, 2023</xref>; <xref ref-type="bibr" rid="B39">Qaqish et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B6">Albayat et&#xa0;al., 2024</xref>). The adopted questions were forward translated from English to Arabic by bi-lingual members of the research team. An expert back translated the questionnaire from Arabic to English to ensure equivalence. The final Arabic questionnaire was evaluated by an expert committee of medical and public health experts.</p>
<p>The domains and items comprising the HPV and HPV vaccine knowledge scores were examined for content validity and reliability. Results from the expert committee assessment revealed a Scale &#x2013; Content Validity Index for the HPV and HPV vaccine knowledge scales of 0.831 and 0.764, respectively. After ensuring content validity, the questionnaire was pilot tested on 20 medical students for confirm clarity, understandability, relevance, and reliability prior to initiating data collection. Cronbach&#x2019;s &#x3b1; values for the HPV knowledge and HPV vaccine knowledge domains were 0.756 and 0.692, respectively.</p>
<p>The final tool was comprised of 4 domains pertaining to sociodemographic characteristics, knowledge regarding HPV infection and vaccine, attitudes towards HPV infection and vaccine. The sociodemographic domain included among others questions about sex, age, country of origin, marital status, as well as the level of study and the university attended by each participant. The 2<sup>nd</sup> domain assessing the participants&#x2019; knowledge of HPV infection consisted of 14 items, each with a single correct answer, and participants answers were scored based on the number of correct responses they provided. The 3<sup>rd</sup> domain, which evaluated participants&#x2019; knowledge of the HPV vaccine, included eight items and followed the same scoring protocol as the previous section. The final domain included questions assessing the student&#x2019;s willingness to self-vaccinate, recommending the vaccine to family members, or recommending it to patients, as well as questions about the factors that could influence these decisions.</p>
</sec>
<sec id="s2_4">
<title>Sample size and data collection</title>
<p>Given the descriptive nature of our study and the logistical challenges of surveying medical students with demanding schedules, convenience sampling provided a practical and cost-effective solution. However, we acknowledge that convenience sampling may introduce some limitations, and we discussed these in a subsection of the discussion.</p>
<p>A minimum of 384 responses was determined using Cochran&#x2019;s formula (N = (Z<sup>2</sup> p(1-p)/e<sup>2</sup>). We set the confidence level at 95% (Z = 1.96), specified a maximum margin of error of &#xb1;5% (E = 0.05), and used the conservative proportion p = 0.50 to ensure the largest required sample size. A total of 473 responses were included in the study to ensure adequate representation of the study population.</p>
<p>The data was collected using an Arabic self-administered online survey, which was placed on Google Forms and disseminated through the official WhatsApp, Facebook, and Microsoft Teams groups for all six medical schools included in the study. The inclusion criteria were: Full-time registered undergraduate medical students aged 18 years and above from all six public medical schools in Jordan. We targeted medical students from both the basic years (1<sup>st</sup> &#x2013; 3<sup>rd</sup> year) and the clinical years (4<sup>th</sup> &#x2013; 6<sup>th</sup> year) to ensure a comprehensive representation of different stages in medical education. The exclusion criteria were medical students aged less than 18 years and unregistered medical students.</p>
</sec>
<sec id="s2_5">
<title>Ethical considerations</title>
<p>This study was approved by Institutional Review Boards (IRB) of the Hashemite University (No. 22/7/2021/2022) and the University of Jordan (No.446/2024/2025). All the participants provided a written consent prior to participating in this study. The researchers adhered to strict ethical guidelines and ensured the anonymity of all participants.</p>
</sec>
<sec id="s2_6">
<title>Statistical analysis</title>
<p>Data was imported in and analyzed using R (version 4.3.3). Continuous variables were summarized as mean and standard deviation, while categorical variables were summarized as counts and percentages. Associations between categorical variables were assessed using the chi-squared test. Mean differences (MD) in continuous variables were assessed using the independent sample-t test. Predictors to self-vaccinate, recommending vaccination to friends/family, and recommending vaccination to patients were examined using a binary logistic regression model. Each predictor variable was expressed using odds ratios (OR) and their associated 95% confidence interval (95%CI). Figures were produced using GraphPrism 8.3.4. A p-value of &lt; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Characteristics of the included sample</title>
<p>A total of 473 medical students were included in the final analysis with a male-to-female ratio of 0.76-to-1.00 (43.3%-to-56.7%). The majority of participating medical students were single (97.5%), of Jordanian origin (91.1%), and studying at the basic medical sciences level (64.5%). While 53.5 were older than 20 years, 46.5% were younger than 20 years of age. In terms of sampled medical schools, most participants were recruited from the Hashemite University (68.7%), University of Jordan (13.1%), and Yarmouk University (9.7%). The other participants were recruited from Al-Balqa&#x2019; Applied University (5.1%), Jordan University of Science and Technology (3.0%), and Mutah University (0.4%). When asked about their sources on HPV-related knowledge, medical education (56.4%), self-reading (23.3%), and social media (12.9%) were the most common. <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref> demonstrates the characteristics of study participants.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Characteristics of included participants.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Variable</th>
<th valign="middle" align="left">Category</th>
<th valign="middle" align="left">N</th>
<th valign="middle" align="left">%</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="2" align="left">Sex</td>
<td valign="middle" align="left">Male</td>
<td valign="middle" align="left">205</td>
<td valign="middle" align="left">43.3</td>
</tr>
<tr>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">268</td>
<td valign="middle" align="left">56.7</td>
</tr>
<tr>
<td valign="middle" rowspan="6" align="left">Year of study</td>
<td valign="middle" align="left">1<sup>st</sup>
</td>
<td valign="middle" align="left">122</td>
<td valign="middle" align="left">25.8</td>
</tr>
<tr>
<td valign="middle" align="left">2<sup>nd</sup>
</td>
<td valign="middle" align="left">125</td>
<td valign="middle" align="left">26.4</td>
</tr>
<tr>
<td valign="middle" align="left">3<sup>rd</sup>
</td>
<td valign="middle" align="left">58</td>
<td valign="middle" align="left">12.3</td>
</tr>
<tr>
<td valign="middle" align="left">4<sup>th</sup>
</td>
<td valign="middle" align="left">62</td>
<td valign="middle" align="left">13.1</td>
</tr>
<tr>
<td valign="middle" align="left">5<sup>th</sup>
</td>
<td valign="middle" align="left">65</td>
<td valign="middle" align="left">13.7</td>
</tr>
<tr>
<td valign="middle" align="left">6<sup>th</sup>
</td>
<td valign="middle" align="left">41</td>
<td valign="middle" align="left">8.7</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Country of origin</td>
<td valign="middle" align="left">Jordanian</td>
<td valign="middle" align="left">431</td>
<td valign="middle" align="left">91.1</td>
</tr>
<tr>
<td valign="middle" align="left">Non-Jordanian</td>
<td valign="middle" align="left">42</td>
<td valign="middle" align="left">8.9</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Marital status</td>
<td valign="middle" align="left">Married</td>
<td valign="middle" align="left">12</td>
<td valign="middle" align="left">2.5</td>
</tr>
<tr>
<td valign="middle" align="left">Single</td>
<td valign="middle" align="left">461</td>
<td valign="middle" align="left">97.5</td>
</tr>
<tr>
<td valign="middle" rowspan="6" align="left">University</td>
<td valign="middle" align="left">Balqa&#x2019; Applied University</td>
<td valign="middle" align="left">24</td>
<td valign="middle" align="left">5.1</td>
</tr>
<tr>
<td valign="middle" align="left">Hashemite University</td>
<td valign="middle" align="left">325</td>
<td valign="middle" align="left">68.7</td>
</tr>
<tr>
<td valign="middle" align="left">University of Jordan</td>
<td valign="middle" align="left">62</td>
<td valign="middle" align="left">13.1</td>
</tr>
<tr>
<td valign="middle" align="left">Jordan University of Science and Technology</td>
<td valign="middle" align="left">14</td>
<td valign="middle" align="left">3.0</td>
</tr>
<tr>
<td valign="middle" align="left">Mutah University</td>
<td valign="middle" align="left">2</td>
<td valign="middle" align="left">0.4</td>
</tr>
<tr>
<td valign="middle" align="left">Yarmouk University</td>
<td valign="middle" align="left">46</td>
<td valign="middle" align="left">9.7</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_2">
<title>Knowledge of HPV</title>
<p>Among the included medical students, 72.3% reported self-perceived familiarity with HPV, while 22.8% did not, and 4.9% being neutral. Of all included participants, only 27.5% believed that HPV is common in Jordan, 35.7% being neutral, and 36.8% disagreeing. In terms of infection susceptibility, 68.7% of students believe that HPV could affect both males and females, while 15.6% and 2.3% stated that it can only affect females or males, respectively. Moreover, 58.6% of participants recognized that HPV could be asymptomatic and 54.8% knew that sexual intercourse is not the only medium for virus transmission. Among the latter, skin-to-skin transmission was recognized by 45.0%, skin-to-mucosa transmission by 56.1%, mother-to-fetus transmission by 48.6%, transmission through contaminated medical equipment by 49.1%, transmission through contaminated water by 20.1%, and transmission through self-inoculation by 36.6%.</p>
<p>When asked about the most important risk of HPV in females, cancer (52.6%) was most perceived compared to genital warts (18.8%) or skin warts (6.6%). On the other hand, when asked about the most important risk of HPV in males, 38.3% noted genital warts, 14.4% reported skin warts, and only 13.5% considered cancer. In terms of HPV treatment, 55.8% of participants believed that it can be cured compared to 30.0% neutral participants and 14.2% denying such possibility. Finally, only 27.9% of participants correctly recognized that cervical cytology should be conducted once every three years. <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref> demonstrates the responses to HPV knowledge items.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Responses to items pertaining to knowledge of HPV.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Question</th>
<th valign="middle" align="left">Correct response</th>
<th valign="middle" align="left">N</th>
<th valign="middle" align="left">%</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">HPV is common in Jordan</td>
<td valign="middle" align="left">No</td>
<td valign="middle" align="left">174</td>
<td valign="middle" align="left">36.8</td>
</tr>
<tr>
<td valign="middle" align="left">Who are susceptible to HPV infections?</td>
<td valign="middle" align="left">Both males and females</td>
<td valign="middle" align="left">325</td>
<td valign="middle" align="left">68.7</td>
</tr>
<tr>
<td valign="middle" align="left">HPV infection can be asymptomatic</td>
<td valign="middle" align="left">Yes</td>
<td valign="middle" align="left">277</td>
<td valign="middle" align="left">58.6</td>
</tr>
<tr>
<td valign="middle" align="left">HPV is transmitted through sexual intercourse only</td>
<td valign="middle" align="left">No</td>
<td valign="middle" align="left">259</td>
<td valign="middle" align="left">54.8</td>
</tr>
<tr>
<td valign="middle" align="left">Skin-to-skin contact is a route for HPV transmission</td>
<td valign="middle" align="left">Yes</td>
<td valign="middle" align="left">173</td>
<td valign="middle" align="left">44.8</td>
</tr>
<tr>
<td valign="middle" align="left">Skin-to-mucosa contact is a route for HPV transmission</td>
<td valign="middle" align="left">Yes</td>
<td valign="middle" align="left">217</td>
<td valign="middle" align="left">56.4</td>
</tr>
<tr>
<td valign="middle" align="left">Mother-to-fetus contact is a route for HPV transmission</td>
<td valign="middle" align="left">Yes</td>
<td valign="middle" align="left">197</td>
<td valign="middle" align="left">50.5</td>
</tr>
<tr>
<td valign="middle" align="left">Contaminated medical equipment is a route for HPV transmission</td>
<td valign="middle" align="left">Yes</td>
<td valign="middle" align="left">193</td>
<td valign="middle" align="left">50.8</td>
</tr>
<tr>
<td valign="middle" align="left">Contaminated water is a route for HPV transmission</td>
<td valign="middle" align="left">No</td>
<td valign="middle" align="left">121</td>
<td valign="middle" align="left">32.8</td>
</tr>
<tr>
<td valign="middle" align="left">Self-inoculation is a route for HPV transmission</td>
<td valign="middle" align="left">Yes</td>
<td valign="middle" align="left">139</td>
<td valign="middle" align="left">37.2</td>
</tr>
<tr>
<td valign="middle" align="left">The major risk of HPV in females is</td>
<td valign="middle" align="left">Cancer</td>
<td valign="middle" align="left">249</td>
<td valign="middle" align="left">52.6</td>
</tr>
<tr>
<td valign="middle" align="left">The major risk of HPV in males is</td>
<td valign="middle" align="left">Cancer</td>
<td valign="middle" align="left">64</td>
<td valign="middle" align="left">13.5</td>
</tr>
<tr>
<td valign="middle" align="left">Can HPV be treated</td>
<td valign="middle" align="left">No</td>
<td valign="middle" align="left">67</td>
<td valign="middle" align="left">14.2</td>
</tr>
<tr>
<td valign="middle" align="left">How often should cervical cytology be performed</td>
<td valign="middle" align="left">Once every 3 years</td>
<td valign="middle" align="left">132</td>
<td valign="middle" align="left">27.9</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The mean knowledge score for HPV was 5.37 &#xb1; 3.15 ranging from 0 to 12. Participants in their clinical years had significantly higher knowledge scores compared to their counterparts in basic years (MD: -2.92; 95%CI: -3.45 &#x2013; -2.38). Similarly, female participants had significantly higher knowledge scores than their male counterparts (MD: 1.07; 95%CI: 0.51 &#x2013; 1.64). Finally, participants with perceived familiarity of HPV had higher knowledge scores compared to their counterparts (MD: -3.84; 95%CI: -4.37 &#x2013; -3.31). There were no significant differences in knowledge scores in terms of nationality or marital status (p = 0.142 and 0.753, respectively).</p>
</sec>
<sec id="s3_3">
<title>Knowledge of HPV vaccine</title>
<p>Among included participants, 49.0% noted a self-perceived familiarity with HPV vaccine, 30.9% did not, while 20.1% were neutral. The majority of participants did not know if the vaccine is protective for persons infected with HPV, while 35.9% responded that it isn&#x2019;t. About 27.7% believed that individuals with HPV-related genital warts are indicated to take the vaccine. Similarly, only 25.2% believe that there exist indications for vaccinating young males. While 41.9% recognized the most optimal time for HPV vaccination, 33.6% were neutral, 15.6% reported &#x201c;after marriage/sexual activity&#x201d;, and 8.9% recommended vaccination of children under the age of 8 years. In terms of vaccine dosage, an optimal dose of three was recognized as the most optimal by 55.4% of participants. The majority of participants believed that persons between the ages of 14 to 45 should be vaccinated against HPV-related disease (56.9%). Nonetheless, only 16.9% were able to recognize the estimated percentage of prevented cervical cancers by the vaccine at 90%. Similarly, only 31.3% of participants knew that the HPV vaccine is available in Jordan. <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref> demonstrates the responses to HPV vaccine knowledge items.</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Responses to items pertaining to knowledge of HPV vaccine.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Question</th>
<th valign="middle" align="left">Response</th>
<th valign="middle" align="left">N</th>
<th valign="middle" align="left">%</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">The vaccine is protective for persons already infected with HPV</td>
<td valign="middle" align="left">No</td>
<td valign="middle" align="left">170</td>
<td valign="middle" align="left">35.9</td>
</tr>
<tr>
<td valign="middle" align="left">Persons suffering from HPV-related genital warts are indicated to be vaccinated against HPV</td>
<td valign="middle" align="left">Yes</td>
<td valign="middle" align="left">131</td>
<td valign="middle" align="left">27.7</td>
</tr>
<tr>
<td valign="middle" align="left">There are indications for vaccinating young males against HPV</td>
<td valign="middle" align="left">Yes</td>
<td valign="middle" align="left">119</td>
<td valign="middle" align="left">25.2</td>
</tr>
<tr>
<td valign="middle" align="left">What is the best time to get vaccinated against HPV</td>
<td valign="middle" align="left">Children aged 9 &#x2013; 13 or before marriage/sexual activity</td>
<td valign="middle" align="left">198</td>
<td valign="middle" align="left">41.9</td>
</tr>
<tr>
<td valign="middle" align="left">How many doses of HPV vaccine are recommended in a life time</td>
<td valign="middle" align="left">Three doses</td>
<td valign="middle" align="left">262</td>
<td valign="middle" align="left">55.4</td>
</tr>
<tr>
<td valign="middle" align="left">Can individuals aged 14 to 45 be vaccinated to protect against genital warts or cancer</td>
<td valign="middle" align="left">Yes</td>
<td valign="middle" align="left">269</td>
<td valign="middle" align="left">56.9</td>
</tr>
<tr>
<td valign="middle" align="left">The vaccine is available in Jordan</td>
<td valign="middle" align="left">Yes</td>
<td valign="middle" align="left">148</td>
<td valign="middle" align="left">31.3</td>
</tr>
<tr>
<td valign="middle" align="left">What is the estimated percentage of cervical cancers prevented by the HPV vaccine?</td>
<td valign="middle" align="left">90%</td>
<td valign="middle" align="left">80</td>
<td valign="middle" align="left">16.9</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The mean knowledge score of HPV vaccine was 2.91 &#xb1; 1.88 ranging from 0 to 8. Participants in their clinical years had significantly higher vaccine knowledge scores compared to their counterparts in basic years (MD: -1.45; 95%CI: -1.79 &#x2013; -1.12). Similarly, female participants had significantly higher vaccine knowledge scores than their male counterparts (MD: 0.34; 95%CI: 0.01 &#x2013; 0.68). Finally, participants with perceived familiarity of HPV had higher vaccine knowledge scores compared to their counterparts (MD: -1.62; 95%CI: -1.92 &#x2013; -1.31). There were no significant differences in vaccine knowledge scores in terms of nationality or marital status (p = 0.151 and 0.764, respectively).</p>
</sec>
<sec id="s3_4">
<title>Attitudes towards HPV vaccination</title>
<p>About 42.1% of participants believe that it should be obligatory to vaccinate against HPV while 24.7% disagreed with such notion. When asked about the possibility of self-vaccination, 39.3% would take the HPV vaccine if its available for free in Jordan. Among those that declined such possibility, being a virgin (56.7%), having no extra marital sex (45.2%), and not being a female (35.4%) were the most common reasons for rejecting the vaccine (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Most commonly reported barriers for self-vaccination against HPV.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1657090-g001.tif">
<alt-text content-type="machine-generated">Bar chart illustrating reasons for hesitation towards HPVvaccination among the study participants. Categories include being a virgin, not having extramarital sex, not being female, doubting vaccine efficacy, doubting vaccine safety, and cost. Responses are divided into &#x201c;Yes,&#x201d; &#x201c;No,&#x201d; and &#x201c;I don't know,&#x201d; with percentage labelsfor each.</alt-text>
</graphic>
</fig>
<p>Moreover, 56.7% would recommend the vaccine to a family member, while 59.4% would recommend it to patients. Among those that would not recommend the vaccine to a family member, doubts about the vaccine safety (23.9%) and efficacy (22.1%) were prevalent (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). Similarly, doubts over vaccine safety were the most common barrier to recommending the vaccine to patients (24.2%).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Most commonly reported barriers to recommending HPV vaccines to <bold>(A)</bold> friends and family and <bold>(B)</bold> patients.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1657090-g002.tif">
<alt-text content-type="machine-generated">Bar graphs labeled A and B compare responses to the common barriers to recommending HPV vaccines to (A) friends and family and (B) patients. These barriers include Efficacy, Safety, and Cultural/Religious. In both graph A and graph B most responses were &#x201c;I don't know,&#x201d; followed by &#x201c;No,&#x201d; and lastly &#x201c;Yes&#x201d;.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_5">
<title>Predictors of intention to vaccinate</title>
<p>Intention to self-vaccinate against HPV was predicted by higher HPV knowledge scores (OR: 1.12; 95%CI: 1.03 &#x2013; 1.22) and higher vaccine knowledge scores (OR: 1.20; 95%CI: 1.06 &#x2013; 1.36). Male participants were significantly less likely to self-vaccinate compared to females (OR: 0.61; 95%CI: 0.40 &#x2013; 0.91). Similarly, participants with higher HPV knowledge scores (OR: 1.14; 95%CI: 1.05 &#x2013; 1.23), higher HPV vaccine knowledge scores (OR: 1.26; 95%CI: 1.10 &#x2013; 1.43), and are in their clinical studies (OR: 1.68; 95%CI: 1.05 &#x2013; 2.70) were more likely to recommend the HPV vaccine to their family. Conversely, single participants were less likely to recommend that vaccine to family (OR: 0.18; 95%CI: 0.03 &#x2013; 0.93). Finally, participants with higher HPV knowledge scores (OR: 1.16; 95%CI: 1.07 &#x2013; 1.26), higher HPV vaccine knowledge scores (OR: 1.29; 95%CI: 1.12 &#x2013; 1.47), and are in their clinical studies (OR: 1.80; 95%CI: 1.10 &#x2013; 2.95) were more likely to recommend the HPV vaccine to their patients. On the other hand, male participants were significantly less likely to recommend the vaccine to patients compared to their female counterparts (OR: 0.62; 95%CI: 0.40 &#x2013; 0.95). <xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref> demonstrates the binary logistic regression model for the predictors of all three intentions with regards to the HPV vaccine.</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Binary logistic regression of the predictors of intention to self-vaccinate, recommending HPV vaccine to family, and recommending HPV vaccine to patients.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left"/>
<th valign="middle" colspan="2" align="left">Self-vaccinate</th>
<th valign="middle" colspan="2" align="left">Vaccinate family</th>
<th valign="middle" colspan="2" align="left">Vaccinate patients</th>
</tr>
<tr>
<th valign="middle" align="left">Variable</th>
<th valign="middle" align="left">OR</th>
<th valign="middle" align="left">95%CI</th>
<th valign="middle" align="left">OR</th>
<th valign="middle" align="left">95%CI</th>
<th valign="middle" align="left">OR</th>
<th valign="middle" align="left">95%CI</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">HPV knowledge score</td>
<td valign="middle" align="left">
<bold>1.12</bold>
</td>
<td valign="middle" align="left">
<bold>1.03 &#x2013; 1.22</bold>
</td>
<td valign="middle" align="left">
<bold>1.14</bold>
</td>
<td valign="middle" align="left">
<bold>1.05 &#x2013; 1.23</bold>
</td>
<td valign="middle" align="left">
<bold>1.16</bold>
</td>
<td valign="middle" align="left">
<bold>1.07 &#x2013; 1.26</bold>
</td>
</tr>
<tr>
<td valign="middle" align="left">Vaccine knowledge score</td>
<td valign="middle" align="left">
<bold>1.20</bold>
</td>
<td valign="middle" align="left">
<bold>1.06 &#x2013; 1.36</bold>
</td>
<td valign="middle" align="left">
<bold>1.26</bold>
</td>
<td valign="middle" align="left">
<bold>1.10 &#x2013; 1.43</bold>
</td>
<td valign="middle" align="left">
<bold>1.29</bold>
</td>
<td valign="middle" align="left">
<bold>1.12 &#x2013; 1.47</bold>
</td>
</tr>
<tr>
<td valign="middle" align="left">Stage of study (i.e., Clinical)</td>
<td valign="middle" align="left">1.49</td>
<td valign="middle" align="left">0.96 &#x2013; 2.34</td>
<td valign="middle" align="left">
<bold>1.68</bold>
</td>
<td valign="middle" align="left">
<bold>1.05 &#x2013; 2.70</bold>
</td>
<td valign="middle" align="left">
<bold>1.80</bold>
</td>
<td valign="middle" align="left">
<bold>1.10 &#x2013; 2.95</bold>
</td>
</tr>
<tr>
<td valign="middle" align="left">Sex (i.e., Male)</td>
<td valign="middle" align="left">
<bold>0.61</bold>
</td>
<td valign="middle" align="left">
<bold>0.40 &#x2013; 0.91</bold>
</td>
<td valign="middle" align="left">0.70</td>
<td valign="middle" align="left">0.46 &#x2013; 1.06</td>
<td valign="middle" align="left">
<bold>0.62</bold>
</td>
<td valign="middle" align="left">
<bold>0.40 &#x2013; 0.95</bold>
</td>
</tr>
<tr>
<td valign="middle" align="left">Marital Status (i.e., Married)</td>
<td valign="middle" align="left">0.18</td>
<td valign="middle" align="left">0.21 &#x2013; 1.47</td>
<td valign="middle" align="left">
<bold>0.18</bold>
</td>
<td valign="middle" align="left">
<bold>0.03 &#x2013; 0.93</bold>
</td>
<td valign="middle" align="left">0.31</td>
<td valign="middle" align="left">0.07 &#x2013; 1.33</td>
</tr>
<tr>
<td valign="middle" align="left">Country of Origin (i.e., Jordanian)</td>
<td valign="middle" align="left">0.69</td>
<td valign="middle" align="left">0.34 &#x2013; 1.39</td>
<td valign="middle" align="left">1.09</td>
<td valign="middle" align="left">0.53 &#x2013; 2.27</td>
<td valign="middle" align="left">1.36</td>
<td valign="middle" align="left">0.65 &#x2013; 2.84</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Bold OR values lie within 95% CI.</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>In this study, we demonstrated an alarming gap in HPV and vaccine knowledge among medical students. Only 72.3% were aware of the disease, while only 49.0% were aware of the vaccine. Significant knowledge gaps exist for epidemiology, treatment, transmission, and vaccination for HPV. Intention to self-vaccinate was lower than willingness to recommend the vaccine to family or patients. Factors associated with intention to vaccinate or recommending the vaccine were female gender, higher knowledge scores, and being in the clinical phase of undergraduate medical studies.</p>
<p>These findings, while alarming, are parallel to the existing body of literature. Poor HPV awareness, vaccine knowledge, and subpar intention to vaccinate were documented among university students in Saudi Arabia, Kuwait, Qatar, Iran, Morocco, Oman, Bahrain, and India (<xref ref-type="bibr" rid="B23">Ghojazadeh et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B41">Rashid et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B10">Alshammari and Khan, 2022</xref>; <xref ref-type="bibr" rid="B14">Bencherit et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B20">El Mansouri et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B52">Yacouti et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B9">Alsanafi et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B7">Alghalyini et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B16">Cheema et&#xa0;al., 2024</xref>). Interestingly, a similar trend was found across studies focusing on exclusively medical students (<xref ref-type="bibr" rid="B31">Mehta et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B21">Farsi et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B24">Haddad et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B1">Abdelaziz et&#xa0;al., 2025</xref>). A reliable explanation for this phenomenon originates in the sociocultural characteristics of the Middle East and North Africa (MENA) region. The MENA region is a conservative culture dominated by Islamic practices (<xref ref-type="bibr" rid="B3">Abi Jaoude et&#xa0;al., 2018</xref>). While the earlier could lead individuals to believe that safer sexual practices may lead to promiscuity and tarnish family prestige, the latter considers any extra-marital sexual activities to divinely prohibited; therefore, there exists a regional taboo on discussing any matters related to sexual activity (<xref ref-type="bibr" rid="B25">Hamdi, 2017</xref>).</p>
<p>On a more locally focused note, the Hashemite Kingdom of Jordan is known for an extremely limited cancer screening and prevention program, which only pertains to breast cancer (<xref ref-type="bibr" rid="B11">Al-Shamsi et&#xa0;al., 2022</xref>). Screening for cervical cancers through &#x201c;pap smears&#x201d;, prevention through vaccines, or even raising awareness through campaigns are yet to be complied into a policy despite somewhat shy efforts to promote prevention by private institutions and individuals. In fact, in a country where the minimum wage is about 410$, the HPV vaccine is estimated to cost 250$. Therefore, vaccination is only limited for those with high-end resources. This is particular importance as vaccine costs represent the most commonly reported factor for HPV vaccine resistance (<xref ref-type="bibr" rid="B22">Gamaoun, 2018</xref>). In response to cost barriers, Murewanhema et&#xa0;al., recommends enhanced vaccine cost coverage by insurance providers, the development of local infrastructure for the production of HPV vaccine, and embedding vaccine administration programs within schools, all of which serves of lower costs within resource limited countries (<xref ref-type="bibr" rid="B32">Murewanhema et&#xa0;al., 2024</xref>). While Jordan does not qualify for the Global Alliance for Vaccines and Immunizations (GAVI) monetary support, concerned policy makers could attempt negotiating cost-effective pricing of vaccines for the economically disadvantaged sectors of the population.</p>
<p>Across the literature, females demonstrated significantly higher knowledge of HPV and its associated vaccine compared to males (<xref ref-type="bibr" rid="B41">Rashid et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B18">Dai et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B48">Teeluck et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B7">Alghalyini et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B17">Chen et&#xa0;al., 2024</xref>). This is attributed to the stereotypical portrayal of HPV and cervical cancer. It could be also explained by the Health Belief Model, as the stereotypical portrayal could enhance the perceived susceptibility of disease among females compared to males (<xref ref-type="bibr" rid="B8">Al-Sabbagh et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B34">Oh et&#xa0;al., 2023</xref>). However, this is not entirely the case for some populations as Rashid et&#xa0;al., demonstrates that despite higher levels of awareness and knowledge of HPV, females were less likely to vaccinate compared to their male counterparts (<xref ref-type="bibr" rid="B41">Rashid et&#xa0;al., 2016</xref>). It is believed that such hesitancy stems from societal, religious, and prejudice ideas as well as poor socioeconomic status.</p>
<p>There is a consistent trend throughout the literature for a higher intention to vaccinate among those with biological/medical backgrounds, university degrees, or have received dedicated sexual education courses (<xref ref-type="bibr" rid="B41">Rashid et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B18">Dai et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B20">El Mansouri et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B52">Yacouti et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B17">Chen et&#xa0;al., 2024</xref>). The Theory of Planned Behavior (TPB) encapsulates such findings as it demonstrates that one&#x2019;s attitudes and subjective norms affect behavior indirectly through behavioral intentions which are considered a direct precursor of behavior (<xref ref-type="bibr" rid="B4">Ajzen, 1991</xref>); this phenomenon is well documented for HPV vaccination intentions (<xref ref-type="bibr" rid="B45">Shah et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B35">Orji et&#xa0;al., 2025</xref>). Therefore, should all environmental factors be constant, better education will encourage individuals to pay more attention to potential diseases and have positive attitudes toward taking meaningful measures to either prevent the problem or cope with it. Unfortunately, while a plethora of studies indicate gaps within their sexual education programs at both the secondary and graduate levels, such courses are not provided within Jordanian institutions nor even attempted. This is owed to the complex interplay of Jordanian socio-religious culture that could stigmatize any efforts involving raising awareness on sex-related matters (<xref ref-type="bibr" rid="B36">Othman et&#xa0;al., 2022</xref>).</p>
<p>Moreover, a number of studies throughout the MENA region documented the role of conspiracy theories in augmenting vaccine hesitancy/resistance. Embracing vaccine conspiracies and vaccine resistance was documented for the COVID-19 vaccine, influenza vaccine, and the HPV vaccine (<xref ref-type="bibr" rid="B28">Knobel et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B37">Pertwee et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B9">Alsanafi et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B12">Alshehri and Sallam, 2023</xref>). This may have an unforeseen impact on participants&#x2019; intentions as nearly 44% of the current sample obtain their HPV-related knowledge through social circles, social media, or self-reading. The latter is particularly important as reliance on internet-based sources was linked with lower intentions to self-vaccinate against HPV (<xref ref-type="bibr" rid="B9">Alsanafi et&#xa0;al., 2023</xref>).</p>
<p>Jordan and so does many of the MENA countries require extensive efforts in promoting HPV knowledge and vaccine uptake. According to the Community Guide&#x2019;s Data Abstraction (CGDA) framework, improving the status of HPV awareness and vaccine uptake must rely on through phases of evidence-based interventions: informational, behavioral, and environmental (<xref ref-type="bibr" rid="B16">Cheema et&#xa0;al., 2024</xref>). At the informational level, concerned authorities must dedicate resources to the development and dissemination of media campaigns to boost knowledge about HPV and its vaccine. A successful example includes the &#x201c;Healthy China 2023&#x201d; plan which is attributed as a significant factor in improving the public&#x2019;s collective knowledge on HPV vaccination and cervical cancer screening (<xref ref-type="bibr" rid="B49">Wang et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B17">Chen et&#xa0;al., 2024</xref>). These campaigns should be mediated through healthcare workers, religious leaders, and social media platforms. The latter is especially relevant as it allows for an active role of susceptible individuals when interacting with information, ultimately contributing to informed health decision-making (<xref ref-type="bibr" rid="B49">Wang et&#xa0;al., 2021</xref>). Such plans should target not only susceptible individuals but also their immediate family as a plethora of studies demonstrated the role of parental encouragement and education in increase HPV vaccine uptake (<xref ref-type="bibr" rid="B2">Abdullahi et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B40">Rani et&#xa0;al., 2022</xref>).</p>
<p>At the behavioral level, the patient-healthcare provider relationship must be revamped to further increase vaccine uptake and general knowledge through providing cues to action (<xref ref-type="bibr" rid="B8">Al-Sabbagh et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B5">Al-Ani et&#xa0;al., 2024</xref>). Examples of these interventions include peer group advocacy, provider-led reminders to get vaccinated, and home visits. Reno et&#xa0;al., emphasizes that healthcare workers should also be trained and equipped with the necessary communication skills as to provide a clear message about the risks of HPV and building rapport with susceptible individuals (<xref ref-type="bibr" rid="B42">Reno et&#xa0;al., 2019</xref>). Improving the trust between patients and providers will likely reduce the impact of misinformation and contribute to the development of a more informed patient. Finally, environmental policies should be adopted at the national level. Governments are encouraged to include HPV vaccine as part of their national vaccination policy or subsidize their costs, making them more accessible. These policies, while cost intensive at an initial glance, may provide significant economic savings in the long-term by preventing HPV-related disease costs.</p>
<p>At the level of medical students, policy makers and university administrations should revise and re-develop their existing curriculums. Medical students, which are considered future practitioners, should be well equipped to prevent HPV across both themselves and their future patients. The content, approach, and style of medical educational materials could be improved as to provide these students with the necessary evidence and theoretical basis for circumventing the disease (<xref ref-type="bibr" rid="B46">Solis-Torres et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B1">Abdelaziz et&#xa0;al., 2025</xref>). Moreover, any changes made should take into consideration the stigma around sexually transmitted diseases which may influence attitudes of even medical students towards the promotion of the vaccine (<xref ref-type="bibr" rid="B1">Abdelaziz et&#xa0;al., 2025</xref>). Medical students should be encouraged and trained to approach these sensitive topics educating the public and addressing hesitancy.</p>
<p>In light of what&#x2019;s above, our findings should be interpreted within the context of a number of limitations. These include the cross-sectional nature of study&#x2019;s design, close-ended questionnaire, and due to logistics, inability of the questionnaire to account for all factors affecting HPV knowledge. Participants may also demonstrate social desirability bias or a neutral bias which might have distorted responses or compromised data accuracy. Additionally, due to the fact that this study is comprised of medical students only, its results cannot be generalized to other university students in non-medical fields or even other medical fields such as nursing or pharmacy. The use of convenience sampling and the over-representation of students from the Hashemite University may also limit the external validity of our findings to all medical students. Certain demographics of students may have been missed by the sampling strategy and since each Jordanian University represents a number of Jordanian prefectures, the over-representation of students from one university may produce results that may not be replicable in other Jordanian institutions. Finally, due to the different answer scales for some questions, the questionnaire was not subjected to an exploratory factor analysis to quantitatively measure its construct validity.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusion</title>
<p>The study implies that the overall awareness and attitudes regarding HPV and its vaccine is alarmingly poor among medical students. Moreover, there exists a gender difference in the knowledge and attitudes favoring females. Our findings call for an urgent need for qualitative research to explore the barriers and facilitators to vaccination. This is necessary for designing multi-faceted, context sensitive, evidence-based interventions at the informational, behavioral, and environmental levels from all concerned authorities to improve knowledge of HPV among young adults and increase vaccine uptake.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Institutional Review Boards (IRB) of the Hashemite University (No. 22/7/2021/2022) and the University of Jordan (No.446/2024/2025). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>HT: Methodology, Supervision, Project administration, Software, Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Formal analysis, Investigation, Data curation, Validation, Conceptualization, Funding acquisition. TA: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Formal analysis. SA: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Formal analysis. RA: Writing &#x2013; review &amp; editing, Formal analysis, Writing &#x2013; original draft. AA-A: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Formal analysis. SA: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft. AA-M: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Formal analysis. AQ: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Data curation, Methodology. AM: Methodology, Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Data curation. DA-S: Data curation, Methodology, Writing &#x2013; review &amp; editing, Writing &#x2013; original draft. VB: Supervision, Validation, Writing &#x2013; review &amp; editing, Formal analysis, Writing &#x2013; original draft.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. The authors declare that this research article publication fees were covered under the national open access agreement between Karolinska Institutet; as a member of Sweden&#x2019;s academic consortium Bibsam and Frontiers journals.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Dr. Mohammad Al Khateeb for his contribution to the Data collection of this research.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s13" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2025.1657090/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2025.1657090/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdelaziz</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Hefnawy</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Azzam</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Reisha</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Hamdy</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Knowledge and attitude among Egyptian medical students regarding the role of human papillomavirus vaccine in prevention of oropharyngeal cancer: a questionnaire-based observational study</article-title>. <source>Sci. Rep.</source> <volume>15</volume>, <fpage>3767</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-025-86853-8</pub-id>, PMID: <pub-id pub-id-type="pmid">39885233</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdullahi</surname> <given-names>L. H.</given-names>
</name>
<name>
<surname>Kagina</surname> <given-names>B. M.</given-names>
</name>
<name>
<surname>Ndze</surname> <given-names>V. N.</given-names>
</name>
<name>
<surname>Hussey</surname> <given-names>G. D.</given-names>
</name>
<name>
<surname>Wiysonge</surname> <given-names>C. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Improving vaccination uptake among adolescents</article-title>. <source>Cochrane Database Syst. Rev.</source> <volume>1</volume>, <fpage>CD011895</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/14651858.CD011895.pub2</pub-id>, PMID: <pub-id pub-id-type="pmid">31978259</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abi Jaoude</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Khair</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Dagher</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Saad</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Cherfan</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Kaafarani</surname> <given-names>M. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Factors associated with Human Papilloma Virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study</article-title>. <source>Vaccine</source> <volume>36</volume>, <fpage>7562</fpage>&#x2013;<lpage>7567</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vaccine.2018.10.065</pub-id>, PMID: <pub-id pub-id-type="pmid">30420044</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ajzen</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>The theory of planned behavior</article-title>. <source>Organ Behav. Hum. Decis. Proc.</source> <volume>50</volume>, <fpage>179</fpage>&#x2013;<lpage>211</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0749-5978(91)90020-T</pub-id>
</citation></ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Ani</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hammouri</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Sultan</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Al-Huneidy</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Mansour</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Al-Hussaini</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Factors affecting cervical screening using the health belief model during the last decade: A systematic review and meta-analysis</article-title>. <source>Psychooncology</source> <volume>33</volume>, <fpage>e6275</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/pon.6275</pub-id>, PMID: <pub-id pub-id-type="pmid">38282232</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albayat</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Mundodan</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Elmardi</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hasnain</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Khogali</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Baaboura</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Knowledge, attitude, and practices regarding human papilloma virus vaccination among physicians in Qatar</article-title>. <source>Womens. Health Lond. Engl.</source> <volume>20</volume>, <fpage>17455057241227360</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/17455057241227360</pub-id>, PMID: <pub-id pub-id-type="pmid">38282514</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alghalyini</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Zaidi</surname> <given-names>A. R. Z.</given-names>
</name>
<name>
<surname>Meo</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Faroog</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Rashid</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Alyousef</surname> <given-names>S. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Awareness and knowledge of human papillomavirus, vaccine acceptability and cervical cancer among college students in Saudi Arabia</article-title>. <source>Hum. Vaccines Immunother.</source> <volume>20</volume>, <fpage>2403844</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21645515.2024.2403844</pub-id>, PMID: <pub-id pub-id-type="pmid">39377296</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Sabbagh</surname> <given-names>M. Q.</given-names>
</name>
<name>
<surname>Al-Ani</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mafrachi</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Siyam</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Isleem</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Massad</surname> <given-names>F. I.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Predictors of adherence with home quarantine during COVID-19 crisis: the case of health belief model</article-title>. <source>Psychol. Health Med.</source> <volume>0</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>., PMID: <pub-id pub-id-type="pmid">33427487</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alsanafi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Salim</surname> <given-names>N. A.</given-names>
</name>
<name>
<surname>Sallam</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs</article-title>. <source>Hum. Vaccines Immunother.</source> <volume>19</volume>, <fpage>2194772</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21645515.2023.2194772</pub-id>, PMID: <pub-id pub-id-type="pmid">37005342</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alshammari</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>K. U.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Knowledge, attitudes and perceptions regarding human papillomavirus among university students in Hail, Saudi Arabia</article-title>. <source>PeerJ</source> <volume>10</volume>, <fpage>e13140</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7717/peerj.13140</pub-id>, PMID: <pub-id pub-id-type="pmid">35345591</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="book">
<person-group person-group-type="editor">
<name>
<surname>Al-Shamsi</surname> <given-names>H. O.</given-names>
</name>
<name>
<surname>Abu-Gheida</surname> <given-names>I. H.</given-names>
</name>
<name>
<surname>Iqbal</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Al-Awadhi</surname> <given-names>A.</given-names>
</name>
</person-group> (Eds.) (<year>2022</year>). <source>Cancer in the arab world</source> (<publisher-loc>Singapore</publisher-loc>: <publisher-name>Springer Singapore</publisher-name>). doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-981-16-7945-2</pub-id>
</citation></ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alshehri</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sallam</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Vaccine conspiracy association with higher COVID-19 vaccination side effects and negative attitude towards booster COVID-19, influenza and monkeypox vaccines: A pilot study in Saudi Universities</article-title>. <source>Hum. Vaccines Immunother.</source> <volume>19</volume>, <fpage>2275962</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21645515.2023.2275962</pub-id>, PMID: <pub-id pub-id-type="pmid">37941437</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Annab</surname> <given-names>A. W.</given-names>
</name>
<name>
<surname>Lataifeh</surname> <given-names>I. M.</given-names>
</name>
<name>
<surname>Dajani</surname> <given-names>Y. F.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Human Papillomavirus in Jordan-A selective study of 650 cases</article-title>. <source>IJID. Reg.</source> <volume>15</volume>, <fpage>100620</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijregi.2025.100620</pub-id>, PMID: <pub-id pub-id-type="pmid">40213027</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bencherit</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Kidar</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Otmani</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sallam</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Samara</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Barqawi</surname> <given-names>H. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Knowledge and awareness of Algerian students about cervical cancer, HPV and HPV vaccines: A cross-sectional study</article-title>. <source>Vaccines</source> <volume>10</volume>, <fpage>1420</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/vaccines10091420</pub-id>, PMID: <pub-id pub-id-type="pmid">36146498</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="book">
<person-group person-group-type="author">
<collab>CDC</collab>
</person-group> (<year>2025</year>). &#x201c;<article-title>Cancers caused by HPV</article-title>,&#x201d; in <source>Human Papillomavirus (HPV)</source>. Available online at: <uri xlink:href="https://www.cdc.gov/hpv/about/cancers-caused-by-hpv.html">https://www.cdc.gov/hpv/about/cancers-caused-by-hpv.html</uri>.</citation></ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheema</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Abraham</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Maisonneuve</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Jithesh</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Chaabna</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Al Janahi</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>HPV infection and vaccination: a cross-sectional study of knowledge, perception, and attitude to vaccine uptake among university students in Qatar</article-title>. <source>BMC Public Health</source> <volume>24</volume>, <fpage>2316</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12889-024-19792-0</pub-id>, PMID: <pub-id pub-id-type="pmid">39187821</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Exploring factors influencing awareness and knowledge of human papillomavirus in Chinese college students: A cross-sectional study</article-title>. <source>Hum. Vaccines Immunother.</source> <volume>20</volume>, <fpage>2388347</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21645515.2024.2388347</pub-id>, PMID: <pub-id pub-id-type="pmid">39140222</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Si</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China</article-title>. <source>J. Med. Virol.</source> <volume>94</volume>, <fpage>2776</fpage>&#x2013;<lpage>2786</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jmv.27478</pub-id>, PMID: <pub-id pub-id-type="pmid">34825712</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Sanjos&#xe9;</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Brotons</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Pav&#xf3;n</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The natural history of human papillomavirus infection</article-title>. <source>Best Pract. Res. Clin. Obstet. Gynaecol.</source> <volume>47</volume>, <fpage>2</fpage>&#x2013;<lpage>13</lpage>.</citation></ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Mansouri</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Ferrera</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Kharbach</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Achbani</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kassidi</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Rogua</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Awareness and knowledge associated to Human papillomavirus infection among university students in Morocco: A cross-sectional study</article-title>. <source>PloS One</source> <volume>17</volume>, <fpage>e0271222</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0271222</pub-id>, PMID: <pub-id pub-id-type="pmid">35802731</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farsi</surname> <given-names>N. J.</given-names>
</name>
<name>
<surname>Baharoon</surname> <given-names>A. H.</given-names>
</name>
<name>
<surname>Jiffri</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Marzouki</surname> <given-names>H. Z.</given-names>
</name>
<name>
<surname>Merdad</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Merdad</surname> <given-names>L. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Human papillomavirus knowledge and vaccine acceptability among male medical students in Saudi Arabia</article-title>. <source>Hum. Vaccines Immunother.</source> <volume>17</volume>, <fpage>1968</fpage>&#x2013;<lpage>1974</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21645515.2020.1856597</pub-id>, PMID: <pub-id pub-id-type="pmid">33522406</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gamaoun</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: a systematic review</article-title>. <source>East. Mediterr. Health J.</source> <volume>24</volume>, <fpage>538</fpage>&#x2013;<lpage>548</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.26719/2018.24.6.538</pub-id>, PMID: <pub-id pub-id-type="pmid">30079949</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghojazadeh</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Azar</surname> <given-names>Z. F.</given-names>
</name>
<name>
<surname>Saleh</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Naghavi-Behzad</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Azar</surname> <given-names>N. G.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Knowledge and attitude of Iranian University students toward human papilloma virus</article-title>. <source>Asian Pac. J. Cancer Prev. APJCP.</source> <volume>13</volume>, <fpage>6115</fpage>&#x2013;<lpage>6119</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7314/APJCP.2012.13.12.6115</pub-id>, PMID: <pub-id pub-id-type="pmid">23464415</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haddad</surname> <given-names>S. F.</given-names>
</name>
<name>
<surname>Kerbage</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Eid</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kourie</surname> <given-names>H. R.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Awareness about the human papillomavirus (HPV) and HPV vaccine among medical students in Lebanon</article-title>. <source>J. Med. Virol.</source> <volume>94</volume>, <fpage>2796</fpage>&#x2013;<lpage>2801</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jmv.27509</pub-id>, PMID: <pub-id pub-id-type="pmid">34877678</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamdi</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The impact of teachings on sexuality in Islam on HPV vaccine acceptability in the Middle East and North Africa region</article-title>. <source>J. Epidemiol. Glob. Health</source> <volume>7</volume>, <fpage>S17</fpage>&#x2013;<lpage>S22</lpage>., PMID: <pub-id pub-id-type="pmid">29801588</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="web">
<person-group person-group-type="author">
<collab>HPV Information Centre</collab>
</person-group> <article-title>Complementary Data on Cervical Cancer Prevention</article-title>. Available online at: <uri xlink:href="https://hpvcentre.net/">https://hpvcentre.net/</uri>.</citation></ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khalil</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Boutros</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hassoun</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hallit</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Barakat</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Human papillomavirus vaccine knowledge and conspiracy beliefs among secondary school students in Lebanon</article-title>. <source>BMC Pediatr.</source> <volume>23</volume>, <fpage>363</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12887-023-04177-w</pub-id>, PMID: <pub-id pub-id-type="pmid">37454098</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knobel</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>X.</given-names>
</name>
<name>
<surname>White</surname> <given-names>K. M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Do conspiracy theory and mistrust undermine people&#x2019;s intention to receive the COVID-19 vaccine in Austria</article-title>? <source>J. Community Psychol.</source> <volume>50</volume>, <fpage>1269</fpage>&#x2013;<lpage>1281</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcop.22714</pub-id>, PMID: <pub-id pub-id-type="pmid">34551127</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kombe Kombe</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Zahid</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mengist</surname> <given-names>H. M.</given-names>
</name>
<name>
<surname>Bounda</surname> <given-names>G. A.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation</article-title>. <source>Front. Public Health</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpubh.2020.552028/full</pub-id>, PMID: <pub-id pub-id-type="pmid">33553082</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahafzah</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Al-Ramahi</surname> <given-names>M. Q.</given-names>
</name>
<name>
<surname>Asa&#x2019;d</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>El-Khateeb</surname> <given-names>M. S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Prevalence of sexually transmitted infections among sexually active Jordanian females</article-title>. <source>Sex. Transm. Dis.</source> <volume>35</volume>, <fpage>607</fpage>&#x2013;<lpage>610</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/OLQ.0b013e3181676bbd</pub-id>, PMID: <pub-id pub-id-type="pmid">18434942</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehta</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Rajaram</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Goel</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Goel</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Awareness about Human Papilloma Virus and its Vaccine Among Medical Students</article-title>. <source>Indian J. Community Med.</source> <volume>38</volume>, <fpage>92</fpage>&#x2013;<lpage>94</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/0970-0218.112438</pub-id>, PMID: <pub-id pub-id-type="pmid">23878421</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murewanhema</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Moyo</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Dzobo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mandishora-Dube</surname> <given-names>R. S.</given-names>
</name>
<name>
<surname>Dzinamarira</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Human papilloma virus vaccination in the resource-limited settings of sub-Saharan Africa: Challenges and recommendations</article-title>. <source>Vaccine X.</source> <volume>20</volume>, <fpage>100549</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jvacx.2024.100549</pub-id>, PMID: <pub-id pub-id-type="pmid">39263366</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nesser</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Ayodele</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Human papilloma virus knowledge among university students, staff, and faculty in the state of Indiana during 2016, 2019, and 2022</article-title>. <source>J. Community Health</source> <volume>48</volume>, <fpage>718</fpage>&#x2013;<lpage>723</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10900-023-01210-y</pub-id>, PMID: <pub-id pub-id-type="pmid">36988774</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oh</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Alqahtani</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Cox</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Knowledge, beliefs, and practice regarding human papillomavirus (HPV) vaccination among American college students: Application of the health belief model</article-title>. <source>J. Am. Coll. Health J. ACH.</source> <volume>71</volume>, <fpage>2329</fpage>&#x2013;<lpage>2338</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/07448481.2021.1967362</pub-id>, PMID: <pub-id pub-id-type="pmid">34586013</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orji</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Barner</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Moczygemba</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Morales-Campos</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Determinants of Human Papillomavirus (HPV) vaccination intentions among young adult college students using the theory of planned behavior</article-title>. <source>J. Am. Coll. Health J. ACH.</source> <volume>73</volume>, <fpage>2660</fpage>&#x2013;<lpage>2673</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/07448481.2024.2325935</pub-id>, PMID: <pub-id pub-id-type="pmid">38466334</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Othman</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Abuidhail</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Shaheen</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Langer</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gausman</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Parents&#x2019; perspectives towards sexual and reproductive health and rights education among adolescents in Jordan: content, timing and preferred sources of information</article-title>. <source>Sex. Educ.</source> <volume>22</volume>, <fpage>628</fpage>&#x2013;<lpage>639</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14681811.2021.1975671</pub-id>
</citation></ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pertwee</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Simas</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Larson</surname> <given-names>H. J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>An epidemic of uncertainty: rumors, conspiracy theories and vaccine hesitancy</article-title>. <source>Nat. Med.</source> <volume>28</volume>, <fpage>456</fpage>&#x2013;<lpage>459</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41591-022-01728-z</pub-id>, PMID: <pub-id pub-id-type="pmid">35273403</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porras</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Tsang</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Herrero</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Guill&#xe9;n</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Darragh</surname> <given-names>T. M.</given-names>
</name>
<name>
<surname>Stoler</surname> <given-names>M. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial</article-title>. <source>Lancet Oncol.</source> <volume>21</volume>, <fpage>1643</fpage>&#x2013;<lpage>1652</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1470-2045(20)30524-6</pub-id>, PMID: <pub-id pub-id-type="pmid">33271093</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qaqish</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Abdo</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Abbas</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Saadeh</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Alkhateeb</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Msameh</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Awareness and knowledge of physicians and residents on the non-sexual routes of human papilloma virus (HPV) infection and their perspectives on anti-HPV vaccination in Jordan</article-title>. <source>PloS One</source> <volume>18</volume>, <fpage>e0291643</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0291643</pub-id>, PMID: <pub-id pub-id-type="pmid">37819974</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rani</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Darabaner</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Seserman</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bednarczyk</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Shaw</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Public education interventions and uptake of human papillomavirus vaccine: A systematic review</article-title>. <source>J. Public Health Manag. Pract. JPHMP.</source> <volume>28</volume>, <fpage>E307</fpage>&#x2013;<lpage>E315</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/PHH.0000000000001253</pub-id>, PMID: <pub-id pub-id-type="pmid">33208719</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rashid</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Labani</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Das</surname> <given-names>B. C.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Knowledge, awareness and attitude on HPV, HPV vaccine and cervical cancer among the college students in India</article-title>. <source>PloS One</source> <volume>11</volume>, <fpage>e0166713</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0166713</pub-id>, PMID: <pub-id pub-id-type="pmid">27861611</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reno</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Thomas</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Pyrzanowski</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lockhart</surname> <given-names>S.</given-names>
</name>
<name>
<surname>O&#x2019;Leary</surname> <given-names>S. T.</given-names>
</name>
<name>
<surname>Campagna</surname> <given-names>E. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Examining strategies for improving healthcare providers&#x2019; communication about adolescent HPV vaccination: evaluation of secondary outcomes in a randomized controlled trial</article-title>. <source>Hum. Vaccines Immunother.</source> <volume>15</volume>, <fpage>1592</fpage>&#x2013;<lpage>1598</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21645515.2018.1547607</pub-id>, PMID: <pub-id pub-id-type="pmid">30433845</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sallam</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Dababseh</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Yaseen</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Al-Haidar</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ettarras</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Jaafreh</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Lack of knowledge regarding HPV and its relation to oropharyngeal cancer among medical students</article-title>. <source>Cancer Rep.</source> <volume>5</volume>, <fpage>e1517</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cnr2.1517</pub-id>, PMID: <pub-id pub-id-type="pmid">34291614</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarhan</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>J.</given-names>
</name>
<name>
<surname>El-Farra</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Rashid</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Collaborating for change: reimagining medical education in Jordan through international partnerships</article-title>. <source>Discov. Educ.</source> <volume>4</volume>, <fpage>2</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s44217-024-00395-1</pub-id>
</citation></ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname> <given-names>S. F. A.</given-names>
</name>
<name>
<surname>Ginossar</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Bentley</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Zimet</surname> <given-names>G.</given-names>
</name>
<name>
<surname>McGrail</surname> <given-names>J. P.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Using the Theory of Planned behavior to identify correlates of HPV vaccination uptake among college students attending a rural university in Alabama</article-title>. <source>Vaccine</source> <volume>39</volume>, <fpage>7421</fpage>&#x2013;<lpage>7428</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vaccine.2021.10.082</pub-id>, PMID: <pub-id pub-id-type="pmid">34772544</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solis-Torres</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Braverman-Diaz</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Rivera-Morales</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Perez-Sanchez</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Perez-Bravo</surname> <given-names>V. S.</given-names>
</name>
<name>
<surname>Neris-Sanchez</surname> <given-names>A. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Medical students&#x2019; knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer</article-title>. <source>Hum. Vaccines Immunother.</source> <volume>20</volume>, <fpage>2344248</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21645515.2024.2344248</pub-id>, PMID: <pub-id pub-id-type="pmid">38659106</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sung</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Ferlay</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Siegel</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Laversanne</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Soerjomataram</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Jemal</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source>CA Cancer J. Clin.</source> <volume>71</volume>, <fpage>209</fpage>&#x2013;<lpage>249</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3322/caac.21660</pub-id>, PMID: <pub-id pub-id-type="pmid">33538338</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teeluck</surname> <given-names>H. K.</given-names>
</name>
<name>
<surname>Bholoa</surname> <given-names>D. K.</given-names>
</name>
<name>
<surname>Keenoo</surname> <given-names>B. S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Level of awareness, attitude and perception about human papilloma virus vaccine among University of Mauritius students</article-title>. <source>Afr. J. Reprod. Health</source> <volume>26</volume>, <fpage>41</fpage>&#x2013;<lpage>48</lpage>., PMID: <pub-id pub-id-type="pmid">37585084</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Lyu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Quality evaluation of HPV vaccine-related online messages in China: a cross-sectional study</article-title>. <source>Hum. Vaccines Immunother.</source> <volume>17</volume>, <fpage>1089</fpage>&#x2013;<lpage>1096</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21645515.2020.1814095</pub-id>, PMID: <pub-id pub-id-type="pmid">33054581</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Human papillomavirus vaccine against cervical cancer: Opportunity and challenge</article-title>. <source>Cancer Lett.</source> <volume>471</volume>, <fpage>88</fpage>&#x2013;<lpage>102</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.canlet.2019.11.039</pub-id>, PMID: <pub-id pub-id-type="pmid">31812696</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="web">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group> (<year>2024</year>). <article-title>Human papillomavirus and cancer</article-title>. Available online at: <uri xlink:href="https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer">https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer</uri> (Accessed June 5, 2025).</citation></ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yacouti</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Elkhoudri</surname> <given-names>N.</given-names>
</name>
<name>
<surname>El Got</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Benider</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hadrya</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Baddou</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco</article-title>. <source>PloS One</source> <volume>17</volume>, <fpage>e0266081</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0266081</pub-id>, PMID: <pub-id pub-id-type="pmid">35395019</pub-id></citation></ref>
</ref-list>
</back>
</article>